Circulating tumor cells in newly diagnosed inflammatory breast cancer

被引:0
作者
Michal Mego
Antonio Giordano
Ugo De Giorgi
Hiroko Masuda
Limin Hsu
Mario Giuliano
Tamer M Fouad
Shaheenah Dawood
Naoto T Ueno
Vicente Valero
Eleni Andreopoulou
Ricardo H Alvarez
Wendy A Woodward
Gabriel N Hortobagyi
Massimo Cristofanilli
James M Reuben
机构
[1] The University of Texas MD Anderson Cancer Center,Department of Hematopathology
[2] The University of Texas MD Anderson Cancer Center,Breast Medical Oncology
[3] The University of Texas MD Anderson Cancer Center,Radiation Oncology
[4] The University of Texas MD Anderson Cancer Center,Morgan Welch Inflammatory Breast Cancer Research Program and Clinic
[5] Comenius University,Department of Medical Oncology
[6] School of Medicine,Medical Oncology
[7] Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) – IRCCS,Department of Clinical Medicine and Surgery
[8] University Federico II,Medical Oncology Department
[9] Dubai Hospital,Present affiliation: Breast Center
[10] Thomas Jefferson University-Kimmel Cancer Center,undefined
来源
Breast Cancer Research | / 17卷
关键词
Overall Survival; Metastatic Breast Cancer; Circulate Tumor Cell; Inflammatory Breast Cancer; mIBC;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 192 条
  • [1] Ueno NT(1997)Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M.D. Anderson Cancer Center Cancer Chemother Pharmacol 40 321-9
  • [2] Buzdar AU(2014)Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes Ann Oncol 25 384-91
  • [3] Singletary SE(2013)Survival differences between patients with metastatic inflammatory and non-inflammatory breast cancer Cancer Res 73 Abstract nr P6-12-02-8
  • [4] Ames FC(2003)Update on the management of inflammatory breast cancer Oncologist 8 141-44
  • [5] McNeese MD(2007)Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease Cancer 110 1436-75
  • [6] Holmes FA(2010)Inflammatory breast cancer: the disease, the biology, the treatment CA Cancer J Clin 60 351-9
  • [7] Masuda H(2000)Molecular biology of breast cancer metastasis: inflammatory breast cancer: clinical syndrome and molecular determinants Breast Cancer Res 2 423-71
  • [8] Brewer TM(2004)Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification Clin Cancer Res 10 7965-103
  • [9] Liu DD(2004)High incidence of HER2 positivity in inflammatory breast cancer Breast 13 97-7
  • [10] Iwamoto T(2004)Prognostic value of p53, MDM-2, and MUC-1 for patients with inflammatory breast carcinoma Cancer 101 913-8